GWM
FNY icon

Geneos Wealth Management’s First Trust Mid Cap Growth AlphaDEX Fund FNY Stock Holding History

Geneos Wealth Management’s Portfolio FNY Stock Details FNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$600K Buy
6,630
+1,392
+27% +$132K 0.01% 637
2025
Q4 		$478K Buy
5,238
+553
+12% +$50.8K 0.01% 679
2025
Q3 		$429K Buy
4,685
+307
+7% +$26.5K 0.01% 696
2025
Q2 		$361K Sell
4,378
-2,194
-33% -$168K 0.01% 805
2025
Q1 		$492K Buy
6,572
+4,509
+219% +$363K 0.01% 897
2024
Q4 		$165K Buy
2,063
+51
+3% +$4.23K 0.01% 903
2024
Q3 		$160K Buy
2,012
+168
+9% +$12.7K 0.01% 831
2024
Q2 		$136K Buy
1,844
+7
+0.4% +$511 0.01% 796
2024
Q1 		$139K Sell
1,837
-45
-2% -$3.15K 0.01% 785
2023
Q4 		$128K Sell
1,882
-76
-4% -$4.67K 0.01% 772
2023
Q3 		$119K Buy
1,958
+57
+3% +$3.64K 0.01% 824
2023
Q2 		$123K Hold
1,901
– – 0.01% 820
2023
Q1 		$113K Sell
1,901
-1,099
-37% -$65.4K 0.01% 807
2022
Q4 		$169K Buy
3,000
+1
+0% +$58 0.01% 677
2022
Q3 		$160K Sell
2,999
-31
-1% -$1.82K 0.01% 666
2022
Q2 		$167K Sell
3,030
-1,300
-30% -$78.9K 0.01% 813
2022
Q1 		$288K Buy
4,330
+102
+2% +$6.75K 0.01% 682
2021
Q4 		$313K Buy
4,228
+206
+5% +$15.4K 0.01% 722
2021
Q3 		$291K Buy
4,022
+486
+14% +$35.8K 0.01% 724
2021
Q2 		$266K Hold
3,536
– – 0.01% 733
2021
Q1 		$248K Buy
3,536
+73
+2% +$5.08K 0.01% 880
2020
Q4 		$234K Buy
3,463
+662
+24% +$39.4K 0.01% 773
2020
Q3 		$146K Hold
2,801
– – 0.01% 794
2020
Q2 		$130K Hold
2,801
– – 0.01% 807
2020
Q1 		$102K Buy
2,801
+380
+16% +$17.2K 0.01% 827
2019
Q4 		$116K Buy
2,421
+2,200
+995% +$102K 0.01% 892
2019
Q3 		$9K Hold
221
– – ﹤0.01% 1922
2019
Q2 		$9K Buy
221
+125
+130% +$5.53K ﹤0.01% 1933
2019
Q1 		$4K Buy
96
+31
+48% +$1.28K ﹤0.01% 2086
2018
Q4 		$2K Sell
65
-40
-38% -$1.6K ﹤0.01% 2195
2018
Q3 		$4K Buy
105
+40
+62% +$1.82K ﹤0.01% 2106
2018
Q2 		$2K Buy
+65
New +$2.76K ﹤0.01% 2103
2018
Q1 		– Sell
-160
Closed -$6K – 2195
2017
Q4 		$6K Hold
160
– – ﹤0.01% 1767
2017
Q3 		$5K Hold
160
– – ﹤0.01% 1750
2017
Q2 		$5K Sell
160
-5
-3% -$170 ﹤0.01% 1713
2017
Q1 		$5K Sell
165
-7
-4% -$230 ﹤0.01% 1680
2016
Q4 		$5K Hold
172
– – ﹤0.01% 1622
2016
Q3 		$5K Sell
172
-24
-12% -$742 ﹤0.01% 1563
2016
Q2 		$5K Sell
196
-283
-59% -$8.27K ﹤0.01% 1512
2016
Q1 		$13K Buy
+479
New +$13K ﹤0.01% 1219

Other funds holding FNY

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Geneos Wealth Management's FNY Position: Q1 2026 in Review

Geneos Wealth Management increased its First Trust Mid Cap Growth AlphaDEX Fund (FNY) stake by 27% in Q1 2026, buying an estimated $132K and bringing the position to 6,630 shares worth $600K. The position accounts for 0.01% of the portfolio, ranked #637.

Geneos Wealth Management first reported a position in FNY in Q1 2016 and has held it in 40 quarters since. 122 funds tracked by Wall St. Rank hold FNY as of Q1 2026.

  • Geneos Wealth Management held 6,630 shares of First Trust Mid Cap Growth AlphaDEX Fund worth $600K as of Q1 2026.
  • Geneos Wealth Management bought 1,392 First Trust Mid Cap Growth AlphaDEX Fund shares in Q1 2026, an estimated $132K.
  • First Trust Mid Cap Growth AlphaDEX Fund made up 0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #637 holding.
  • Geneos Wealth Management first reported a position in First Trust Mid Cap Growth AlphaDEX Fund in Q1 2016 and has held it in 40 quarters since.
  • 122 funds tracked by Wall St. Rank held First Trust Mid Cap Growth AlphaDEX Fund as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.